rs3791851

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000817.3(GAD1):​c.639-1883T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 152,054 control chromosomes in the GnomAD database, including 4,244 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4244 hom., cov: 32)

Consequence

GAD1
NM_000817.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.257

Publications

5 publications found
Variant links:
Genes affected
GAD1 (HGNC:4092): (glutamate decarboxylase 1) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
GAD1 Gene-Disease associations (from GenCC):
  • early infantile epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 89
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAD1NM_000817.3 linkc.639-1883T>C intron_variant Intron 6 of 16 ENST00000358196.8 NP_000808.2 Q99259-1A0A0S2Z3V5Q8IVA8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAD1ENST00000358196.8 linkc.639-1883T>C intron_variant Intron 6 of 16 1 NM_000817.3 ENSP00000350928.3 Q99259-1

Frequencies

GnomAD3 genomes
AF:
0.225
AC:
34194
AN:
151936
Hom.:
4241
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.233
Gnomad EAS
AF:
0.294
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.316
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.264
Gnomad OTH
AF:
0.220
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.225
AC:
34221
AN:
152054
Hom.:
4244
Cov.:
32
AF XY:
0.229
AC XY:
17002
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.129
AC:
5363
AN:
41496
American (AMR)
AF:
0.178
AC:
2722
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
807
AN:
3470
East Asian (EAS)
AF:
0.294
AC:
1522
AN:
5170
South Asian (SAS)
AF:
0.370
AC:
1783
AN:
4814
European-Finnish (FIN)
AF:
0.316
AC:
3347
AN:
10576
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.264
AC:
17965
AN:
67948
Other (OTH)
AF:
0.224
AC:
472
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1338
2676
4014
5352
6690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.235
Hom.:
578
Bravo
AF:
0.209
Asia WGS
AF:
0.319
AC:
1106
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.5
DANN
Benign
0.42
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3791851; hg19: chr2-171698672; API